Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > there is
View:
Post by okgonow on Mar 19, 2024 12:29pm

there is

there is nothing propriatary about what labs is doing why would any company pay huge premiums for something they can start doing themselves with enough money invested???

anyone that thinks a company like Phizer cant start their own production of acid form CBD and any other derrivatives needs to give their head a shake

unless labs has propriatary and patents on any of the drugs that are in development they are just a cog in the wheel that can be replaced anytime by any other supplier 

unless there is something i dont know .... please enlighten me
Comment by okgonow on Mar 19, 2024 12:34pm
and thats why we are trading at .07 +- .015 since April of 2022
Comment by allibabba on Mar 19, 2024 12:39pm
Fair point but that can be said for any company anywhere in the world.  
Comment by alleyesonme on Mar 19, 2024 12:52pm
The value lies in the suite of licenses and certifications for cannabinoids as a pharmaceutical ingredient in respective jurisdictions...the time to obtain such licenses once the facility is built could range between 2-4 years...now the cost....GW JAZZ announced expansion to the existing extraction facility in the U.K at 100 million price tag...Once a large pharmaceutical Corp reaches the point of ...more  
Comment by okgonow on Mar 19, 2024 12:56pm
ok at what price as i said in a earlier post .25? max at this point i woud think?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities